Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 may harm male fertility and damage the reproductive system.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Copper deficiency is linked to post-COVID-19 hair loss in women.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

COVID-19 infection may cause hair loss.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

There's no significant genetic link between male pattern baldness and COVID-19.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.